iBio, Inc. — Director's Dealing 2017

Jun 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2017-05-01

Reporting Person: Chang Glenn (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-01	Stock Option (right to buy)	$0.40	A	60000	Acquired	2027-05-01	Common Stock (60000)	Direct

Footnotes

F1: Vests in equal annual installments over three years beginning 12/1/16.